Cite Filings / KNSA
Feed Companies Filings Check
Sign in

CIK 0001730430 · Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981795578
Phone
7814319100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Filings Insiders Search text
All 778 Financials 118 Shareholder Meetings 10 Executive Compensation 100 Insider Trading 385 Beneficial Ownership Interest 74 Business Combinations 84 Public Offerings 43 Mutual Funds and ETFs 8 Others 156
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-16
  3. DEF 14A Proxy Proxy Statement 2025-04-21
  4. PRE 14A Proxy Proxy Statement (Preliminary) 2025-04-10
  5. DEF 14A Proxy Proxy Statement 2024-04-23
  6. PRE 14A Proxy Proxy Statement (Preliminary) 2024-04-10
  7. DEF 14A Proxy Proxy Statement 2023-04-27
  8. DEF 14A Proxy Proxy Statement 2022-04-28
  9. DEF 14A Proxy Proxy Statement 2021-04-28
  10. DEF 14A Proxy Proxy Statement 2020-04-28
  11. DEF 14A Proxy Proxy Statement 2019-04-17

Page 1 of 1 · 10 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…